NCT00052455View on ClinicalTrials.gov

Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

PHASE3CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

September 30, 2010

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

lomustine

DRUG

procarbazine hydrochloride

DRUG

temozolomide

DRUG

vincristine sulfate

Trial Locations (1)

NW1 2DA

Medical Research Council Clinical Trials Unit, London

All Listed Sponsors

lead

Institute of Cancer Research, United Kingdom

OTHER

NCT00052455 - Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma | Biotech Hunter | Biotech Hunter